Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Purchase | 2024-02-06 10:28 am | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 33,333 | $0.3 | $10,000 | 233,861 (Direct) | View |
| 2024-02-01 Purchase | 2024-02-06 10:27 am | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 33,333 | $0.3 | $10,000 | 224,313 (Direct) | View |
| 2024-02-01 Purchase | 2024-02-06 10:27 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 66,666 | $0.3 | $20,000 | 359,916 (Direct) | View |
| 2024-02-01 Purchase | 2024-02-06 10:27 am | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 166,666 | $0.3 | $50,000 | 836,076 (Direct) | View |
| 2023-08-22 Purchase | 2023-08-23 08:00 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 27,000 | $1.2658 | $34,177 | 36,772 (Direct) | View |
| 2023-08-16 Purchase | 2023-08-16 4:01 pm | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 2,750 | $1.798 | $4,945 | 49,010 (Direct) | View |
| 2022-12-06 Sale | 2023-08-01 5:10 pm | CNS Pharmaceuticals Inc. | CNSP | Priebe Waldemar 10% Owner | 94,298 | $1.4116 | $133,114 | 156,807 (Indirect) | View |
| 2023-04-19 Purchase | 2023-04-21 07:58 am | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 2,500 | $1.7 | $4,250 | 9,673 (Direct) | View |
| 2023-04-17 Purchase | 2023-04-18 08:00 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 3,100 | $3.2 | $9,920 | 9,251 (Direct) | View |
| 2023-04-10 Purchase | 2023-04-17 08:17 am | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 7,173 | $0.74 | $5,308 | 7,173 (Direct) | View |
| 2023-04-12 Purchase | 2023-04-14 4:20 pm | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 15,000 | $0.6939 | $10,409 | 45,010 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-08-06 4:53 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Cortice Biosciences Inc. 10% Owner | 0 | $0 | 573,368 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:53 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Mahery Amy Director | 35,000 | $0 | 77,340 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:52 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 35,000 | $0 | 143,356 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:52 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 35,000 | $0 | 277,188 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:52 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 35,000 | $0 | 276,688 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:51 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 80,000 | $0 | 443 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:51 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director | 35,000 | $0 | 88,648 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:50 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 166,000 | $0 | 1,036,066 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 9:50 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director | 35,000 | $0 | 112,130 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:28 am | N/A 2034-02-01 | CNS Pharmaceuticals Inc. | CNSP | Mahery Amy Director | 12,420 | $0 | 12,420 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:28 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 66,666 | $0 | 233,861 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:27 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 66,666 | $0 | 224,313 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:27 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 133,332 | $0 | 359,916 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:27 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 333,332 | $0 | 836,076 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:01 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 39,475 | $0 | 45,428 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:01 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 39,475 | $0 | 45,428 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:01 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 39,475 | $0 | 45,428 (Direct) | View |
| 2023-09-14 Option Award(A) | 2023-10-12 6:00 pm | N/A 2033-09-14 | CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director | 15,975 | $0 | 26,673 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:00 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director | 26,315 | $0 | 29,815 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:00 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director | 39,475 | $0 | 45,428 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:27 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 68,961 | $0 | 74,914 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:26 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 68,961 | $0 | 74,914 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:24 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 68,961 | $0 | 74,914 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:21 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director | 16,551 | $0 | 74,914 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:20 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director | 45,974 | $0 | 74,914 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:20 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director | 68,961 | $0 | 74,914 (Direct) | View |
| 2023-05-05 Option Award(A) | 2023-08-10 9:14 pm | N/A 2033-05-05 | CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director | 2,099 | $0 | 2,099 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 5:11 pm | N/A 2023-05-05 | CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-04-28 Exercise | 2023-05-01 6:59 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer | 1,250 | $0 | 106,461 (Direct) | View |
| 2023-04-28 Exercise | 2023-05-01 6:59 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 521 | $0 | 38,020 (Direct) | View |